This study finds that peripheral NK and T cells are activated by MWA of breast cancer partly dependent on B cell and CD4+ T cell collaboration, and MWA combined with immune checkpoint inhibitor may be a promising strategy for the treatment of early‐stage breast cancer. The gene discussed is CD4; the disease is breast cancer.